NCT06714604View on ClinicalTrials.gov

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

PHASE3RecruitingINTERVENTIONAL
Enrollment

432

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2033

Conditions
Locally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic CarcinomaPancreas CancerNeoadjuvant ChemotherapySurgeryPancreatectomy
Interventions
DRUG

FOLFIRINOX or gemcitabine-nab-paclitaxel

4 months if treatment

DRUG

FOLFIRINOX or gemcitabine-nab-paclitaxel

6 months of treatment

Trial Locations (1)

41345

RECRUITING

SahlgrenskaUH, Gothenburg

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

lead

Sahlgrenska University Hospital

OTHER